NAGASHIMA Youji    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position   Professor and Division head
論文種別	症例報告
言語種別	英語
査読の有無	査読あり
表題	Atypical hemolytic uremic syndrome diagnosed four yearsafter ABO-incompatible kidney transplantation.
掲載誌名	正式名：Nephrology (Carlton, Vic.) 略　 称：Nephrology (Carlton) ISSNコード：1440-1797(Electronic)1320-5358(Linking)
巻・号・頁	20 Suppl 2,pp.61-5
著者・共著者	Kawaguchi Keiko†, Kawanishi Kunio, Sato Masayo, Itabashi Mitsuyo, Fujii Akiko, Kanetsuna Yukiko, Huchinoue Shouhei, Ohashi Ryuji, Koike Junki, Honda Kazuho, Nagashima Yoji, Nitta Kosaku
発行年月	2015/07
概要	Atypical hemolytic uremic syndrome (aHUS) in allograft kidney transplantation is caused by various factors including rejection, infection, and immunosuppressive drugs. We present a case of a 32 year old woman with aHUS four years after an ABO-incompatible kidney transplantation from a living relative. The primary cause of end-stage renal disease was unknown; however, IgA nephropathy (IgAN) was suspected from her clinical course. She underwent pre-emptive kidney transplantation from her 60 year old mother. The allograft preserved good renal function [serum creatinine (sCr) level 110-130 μmol/L]until a sudden attack of abdominal pain four years after transplant, with acute renal failure (sCr level, 385.3 μmol/L), decreasing platelet count, and hemolytic anemia with schizocytes. On allograft biopsy, there was thrombotic microangiopathy in the glomeruli, with a cellular crescent formation and mesangial IgA and C3 deposition. Microvascular inflammation, such as glomerulitis, peritubular capillaritis, and arteriole endarteritis were also detected. A disintegrin-like and metalloproteinase with thrombospondin type 1 motifs 13 (ADAMTS13) did not decrease and Shiga toxin was not detected. Donor-specific antibodies or autoantibodies, including anti-neutrophil cytoplasmic antibody and anti-glomerular basement membrane (anti-GBM) antibody, were negative. The patient was diagnosed with aHUS and received three sessions of plasmapheresis and methylprednisolone pulse therapy, followed by oral methylprednisolone (0.25-0.5 mg/kg) instead of tacrolimus. She temporarily required hemodialysis (sCr level, 658.3 μmol/L). Thereafter, her sCr level improved to 284.5 μmol/L without dialysis therapy. This case is clinically considered as aHUSafter kidney transplantation, associated with various factors, including rejection, glomerulonephritis, and toxicity from drugs such as tacrolimus.
DOI	10.1111/nep.12465
文献番号	26031589